What is LOPJLB’s current signal on GCTK?

LOPJLB’s latest quantitative signal on GlucoTrack, Inc. (GCTK) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is GCTK in?

GlucoTrack, Inc. (GCTK) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does GlucoTrack, Inc. (GCTK) do?

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

GlucoTrack, Inc. (GCTK)

COMPARE

Healthcare · Medical - Devices · NASDAQ · US

$0.89-19.82%Close

SELLCRISIS · day 49

[SCORES & PROFILE]

FUND: 8
VALUE: 15
GROWTH: 35
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-

GROSS

NET

[VALUATION]

P/E TTM-0.00

P/E FWD-

SECTOR PE20.48

INDUSTRY PE22.31

P/B-0.11

P/FCF-

EV/EBITDA0.02

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.46

ND/EBITDA-

BETA0.68

FAQ

What is LOPJLB’s current signal on GCTK?: LOPJLB’s latest quantitative signal on GlucoTrack, Inc. (GCTK) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is GCTK in?: GlucoTrack, Inc. (GCTK) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does GlucoTrack, Inc. (GCTK) do?: GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

GlucoTrack, Inc. (GCTK)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ